Every result, read before it lands. Judged after.
Sign in
NIFTY 50 22,776.10 +0.98% NIFTY BANK 55,128.40 +0.76% NIFTY IT 28,136.05 -0.59% NIFTY MIDCAP 100 59,761.20 +1.08% NIFTY SMALLCAP 100 19,448.70 +1.56% NIFTY AUTO 25,541.95 +0.47% NIFTY PHARMA 26,549.60 +1.66% NIFTY FMCG 45,205.35 +1.40%
Closed Close 6 Oct

Medicamen Biotech Limited · Q3FY26

Result on 13 Feb 2026, first traded on 16 Feb 2026; judged on 13 Sep 2026. No read was made before it — it is recorded for the base rate. The company's page →

unreadverdict
—the read
-13.9%vs market, 10 sessions
-7.7%T+1

1 · What the read said

No read. Either the company was not on the calendar in the seven days before the result, or it was excluded that week — the trail below says which.

2 · What the result was

from the filing's XBRL

No reported figures on file for this quarter, so the result itself could not be graded — only the share's reaction was.

3 · What the share did

thirty sessions in, the result day, ten out · from the close before the result
session closed upsession closed downNIFTY 50 (market)run-up into the result
-20%-10%0%+10%+20%T−29result · 16 Feb 2026T+10NIFTY 50 -2.4%2 Jan 2026 run-up close +7.4% high +9.0% low +6.5%5 Jan 2026 run-up close +4.2% high +6.7% low +2.4%6 Jan 2026 run-up close +2.5% high +4.7% low +2.2%7 Jan 2026 run-up close +12.3% high +13.2% low +2.9%8 Jan 2026 run-up close +13.3% high +15.1% low +8.2%9 Jan 2026 run-up close +10.5% high +14.6% low +9.0%12 Jan 2026 run-up close +12.1% high +14.6% low +5.4%13 Jan 2026 run-up close +11.3% high +14.6% low +10.5%14 Jan 2026 run-up close +9.2% high +11.7% low +7.9%16 Jan 2026 run-up close +5.7% high +10.4% low +5.0%19 Jan 2026 run-up close +2.5% high +6.0% low +2.1%20 Jan 2026 run-up close +0.3% high +2.5% low -0.6%21 Jan 2026 run-up close +0.5% high +3.5% low -2.8%22 Jan 2026 run-up close +3.4% high +4.2% low +0.6%23 Jan 2026 run-up close -0.7% high +4.2% low -1.8%27 Jan 2026 run-up close +0.5% high +1.8% low -1.4%28 Jan 2026 run-up close 0.0% high +1.6% low -1.6%29 Jan 2026 run-up close -1.8% high +1.3% low -2.4%30 Jan 2026 run-up close -3.2% high -1.3% low -3.7%2 Feb 2026 run-up close +2.2% high +6.7% low -5.0%3 Feb 2026 run-up close +4.3% high +6.5% low +0.9%4 Feb 2026 run-up close +0.8% high +5.5% low -0.7%5 Feb 2026 run-up close -0.2% high +1.7% low -1.2%6 Feb 2026 run-up close -1.1% high +1.9% low -2.0%9 Feb 2026 run-up close +2.2% high +3.6% low -1.7%10 Feb 2026 run-up close +1.4% high +4.2% low +0.6%11 Feb 2026 run-up close -2.5% high +1.9% low -3.6%12 Feb 2026 run-up close -2.6% high -1.3% low -3.7%13 Feb 2026 run-up close 0.0% high +1.9% low -4.0%16 Feb 2026 result day close -4.0% high -0.9% low -5.0%17 Feb 2026 T+1 close -7.7% high -2.7% low -9.9%18 Feb 2026 T+2 close -5.7% high -4.4% low -9.2%19 Feb 2026 T+3 close -9.8% high -4.2% low -10.4%20 Feb 2026 T+4 close -10.5% high -8.7% low -11.4%23 Feb 2026 T+5 close -14.4% high -10.2% low -15.4%24 Feb 2026 T+6 close -15.2% high -14.0% low -16.2%25 Feb 2026 T+7 close -17.3% high -13.3% low -18.4%26 Feb 2026 T+8 close -13.7% high -12.3% low -17.3%27 Feb 2026 T+9 close -14.7% high -12.8% low -15.4%2 Mar 2026 T+10 close -16.3% high -15.7% low -18.8%-4.0% on the dayNIFTY 50 -2.4%Share -16.3%
Close before₹353.30the base every move below is measured from
T+1-7.7%
T+10-16.3%market -2.4%
vs market-13.9%no sector index mapped
Best close after-4.0%traded as high as -0.9% on 16 Feb
Worst close after-17.3%traded as low as -18.8% on 2 Mar
Run-up, 30 sessions-7.4%into the result
52-week range36% below high20% above low
Delivery share
-0.4 points in the fortnight before, against the month before that
Volume
0.93× its prior month, in the fortnight before
Habit held
unknown — could not be checked
Announced
Mon, timing unknown
Peers reporting
0 sector peers reported the same week

4 · Why it went this way

  • No reported figures on file for this quarter, so the result itself could not be judged.
  • No read was made before this result; recorded for the base rate.

A strong or favourable read is right when the share beat the market by more than 2% over ten sessions; weak or unfavourable when it lagged by more. Inside ±2% is flat. Neutral reads make no call.

5 · Every morning's read before it

1 mornings
MorningDays aheadReadRankComp.L1L2L3L4CloseNote
7 Feb simulated 6 excluded — — — — — — — surveillance stage ASM-LT Stage I

A read is made each morning the company is due within seven days. The highlighted morning is the last one before the result — the read this post-mortem judges. Excluded mornings show why the name dropped out that day.

6 · Every session in the window

the last stop · each close, and where it stood against the close before the result
SessionDateOpenHighLowCloseDayFrom baseNIFTY 50 from base
T-28 2 Jan 379.65 385.00 376.40 379.30 — +7.36% +3.37%
T-27 5 Jan 370.10 376.85 361.70 368.00 -2.98% +4.16% +3.06%
T-26 6 Jan 369.85 369.85 361.10 362.25 -1.56% +2.53% +2.78%
T-25 7 Jan 366.85 400.00 363.45 396.70 +9.51% +12.28% +2.63%
T-24 8 Jan 399.80 406.60 382.20 400.20 +0.88% +13.27% +1.59%
T-23 9 Jan 405.00 405.00 385.10 390.25 -2.49% +10.46% +0.83%
T-22 12 Jan 383.10 405.00 372.45 395.95 +1.46% +12.07% +1.25%
T-21 13 Jan 397.90 404.80 390.55 393.25 -0.68% +11.31% +1.03%
T-20 14 Jan 393.65 394.65 381.25 385.65 -1.93% +9.16% +0.76%
T-19 16 Jan 387.85 389.90 371.10 373.60 -3.12% +5.75% +0.88%
T-18 19 Jan 370.00 374.45 360.60 362.05 -3.09% +2.48% +0.45%
T-17 20 Jan 360.25 362.05 351.25 354.20 -2.17% +0.25% -0.94%
T-16 21 Jan 351.00 365.55 343.50 354.90 +0.20% +0.45% -1.23%
T-15 22 Jan 359.40 368.20 355.55 365.45 +2.97% +3.44% -0.71%
T-14 23 Jan 368.00 368.15 347.00 350.85 -4.00% -0.69% -1.66%
T-13 27 Jan 355.10 359.80 348.40 355.20 +1.24% +0.54% -1.16%
T-12 28 Jan 353.40 359.00 347.60 353.25 -0.55% -0.01% -0.50%
T-11 29 Jan 353.00 358.05 344.95 346.90 -1.80% -1.81% -0.20%
T-10 30 Jan 341.70 348.65 340.10 342.10 -1.38% -3.17% -0.59%
T-9 2 Feb 353.70 377.00 335.55 361.20 +5.58% +2.24% -1.50%
T-8 3 Feb 374.90 376.25 356.45 368.40 +1.99% +4.27% +1.01%
T-7 4 Feb 366.85 372.85 350.95 355.95 -3.38% +0.75% +1.20%
T-6 5 Feb 358.95 359.35 349.05 352.70 -0.91% -0.17% +0.67%
T-5 6 Feb 356.35 360.00 346.35 349.55 -0.89% -1.06% +0.87%
T-4 9 Feb 350.00 366.00 347.20 361.10 +3.30% +2.21% +1.56%
T-3 10 Feb 365.00 368.00 355.30 358.40 -0.75% +1.44% +1.82%
T-2 11 Feb 360.00 360.10 340.50 344.60 -3.85% -2.46% +1.90%
T-1 12 Feb 341.00 348.60 340.30 343.95 -0.19% -2.65% +1.32%
base 13 Feb 340.00 360.00 339.00 353.30 +2.72% +0.00% +0.00%
T+1 16 Feb result 350.00 350.00 335.70 339.05 -4.03% -4.03% +0.83%
T+2 17 Feb 342.80 343.65 318.25 326.05 -3.83% -7.71% +1.00%
T+3 18 Feb 324.95 337.60 320.85 333.20 +2.19% -5.69% +1.37%
T+4 19 Feb 338.20 338.45 316.40 318.50 -4.41% -9.85% -0.07%
T+5 20 Feb 318.50 322.45 313.20 316.10 -0.75% -10.53% +0.39%
T+6 23 Feb 316.00 317.35 299.00 302.30 -4.37% -14.44% +0.95%
T+7 24 Feb 303.80 304.00 296.00 299.60 -0.89% -15.20% -0.18%
T+8 25 Feb 303.00 306.15 288.15 292.30 -2.44% -17.27% +0.04%
T+9 26 Feb 295.00 309.80 292.35 305.05 +4.36% -13.66% +0.10%
T+10 27 Feb 303.55 308.00 299.00 301.20 -1.26% -14.75% -1.15%
T+11 2 Mar 289.00 298.00 286.80 295.75 -1.81% -16.29% -2.38%

Prices are end-of-day from the exchange, adjusted for corporate actions. "From base" is the move from the close before the result — the same base every number on this page uses. Sessions before the base are the run-up.